德国398名女性1632张常规宫颈癌筛查涂片审核:TeQaZ研究结果
在德国9个州开展的基于人群的病例对照研究中,两位独立专家细胞学家审核了392名女性(18.9%为病例,81.1%为对照)诊断前/入组前10年内的1632张巴氏涂片,常规评估总体阳性率为4.5%(病例中29.0%),专家审核为7.7%(病例中40.8%),限制在诊断/入组前3年时升至总体11.9%(病例中61.4%),常规评估总体灵敏度为54.9%(病例中66.8%)。
要点
- 常规评估总体阳性率4.5%(病例中29.0%),专家审核为7.7%(病例中40.8%)。
- 限制在诊断/入组前3年,阳性率升至总体11.9%(病例中61.4%)。
- 常规评估总体灵敏度54.9%(病例中66.8%),细胞学质量问题需紧急解决。
核心结论
- 细胞学仍是宫颈癌筛查的重要组成部分,德国的质量问题必须紧急解决。
- 转向客观方法如 primary high-risk HPV 筛查后分诊可能有助于德国消除宫颈癌。
研究设计与样本
- 在德国9个州开展的基于人群的病例对照研究,招募经组织学确诊宫颈癌的病例和无宫颈癌或子宫切除史的社区对照。
- 两位独立专家细胞学家审核病例诊断前10年内/对照入组前10年内的巴氏涂片。
- 共审核392名女性的1632张涂片(18.9%为病例,81.1%为对照)。
主要发现
- 常规评估中总体阳性结果患病率为4.5%(病例中29.0%)。
- 专家审核总体阳性结果患病率为7.7%(病例中40.8%)。
- 限制在诊断/入组前3年,阳性率升至总体11.9%(病例中61.4%)。
- 常规评估总体灵敏度为54.9%(病例中66.8%)。
关键数值与推荐
- 常规评估总体阳性率4.5%(病例中29.0%),专家审核为7.7%(病例中40.8%)。
- 诊断/入组前3年内阳性率总体11.9%(病例中61.4%)。
- 常规评估灵敏度总体54.9%(病例中66.8%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: There is evidence in Germany that half of the cervical cancer (CC) cases had undergone screening frequently in the decade preceding their diagnosis, signaling cytology quality issues. This study investigates routine smear assessment accuracy in Germany. METHODS: Within a population-based case-control study in 9 German states, we recruited cases (women with a histologically confirmed diagnosis of CC) and population controls (women with no history of CC or hysterectomy). Two independent expert cytologists audited Pap smears taken within the 10 years preceding CC diagnosis (cases)/study entry (controls). We report the prevalence of positive results, as well as routine assessment's accuracy, as sensitivity, specificity, false-positive and false-negative rates along with 95% confidence intervals (95% CI). We also examined cases' smear history, to investigate possible false-positive recurrence. RESULTS: We audited 1632 smears of 392 women (18.9% cases, 81.1% controls). In the routine assessment, the overall prevalence of positive results was 4.5% (29.0% among cases). According to the expert audit, the overall prevalence of positive results was 7.7% (40.8% among cases). When restricting analyses to the 3 years preceding diagnosis/study entry, this prevalence increased to 11.9% overall (61.4% among cases). The overall sensitivity of the routine assessment was 54.9% (66.8% for cases). CONCLUSION: As cytology remains an important part of CC screening, quality issues must be urgently addressed in Germany. Shifting to objective methods such as primary high-risk HPV screening followed by triaging may help CC elimination in Germany.
引用
- Tanaka LF, Schoffer O, Schriefer D, et al. An audit of 1632 routinely collected cervical cancer screening smears from 398 women in Germany: Results from the TeQaZ Study. Eur J Cancer. 2024. PMID: 38364626. doi:10.1016/j.ejca.2024.113915
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。